"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808).
暂无分享,去创建一个
M. Nooij | R. Sylvester | L. Beex | R. Rubens | N. Rotmensz | E. Engelsman | J. Wildiers | J. Klijn | Jelle Klijn